Early tandem high-dose ifosfamide, carboplatin, etoposide therapy with stem cell rescue for small-cell lung cancer: brief report on the results of a phase-I/II trial. [electronic resource]
Producer: 20021212Description: 248-53 p. digitalISSN:- 0030-2414
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Blood Cell Count
- Carboplatin -- adverse effects
- Carcinoma, Small Cell -- therapy
- Combined Modality Therapy
- Dose-Response Relationship, Drug
- Etoposide -- adverse effects
- Female
- Granulocyte Colony-Stimulating Factor -- adverse effects
- Hematologic Diseases -- chemically induced
- Hematopoietic Stem Cells -- physiology
- Humans
- Ifosfamide -- adverse effects
- Lung Neoplasms -- therapy
- Male
- Middle Aged
- Survival Rate
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.